Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

SELLAS Life Sciences (SLS) Shares Issued (2020 - 2024)

SELLAS Life Sciences (SLS) has disclosed Shares Issued for 8 consecutive years, with $45.6 million as the latest value for Q4 2024.

  • Quarterly Shares Issued rose 42521.5% to $45.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $46.2 million through Dec 2024, up 10660.84% year-over-year, with the annual reading at $12.6 million for FY2025, 72.71% down from the prior year.
  • Shares Issued for Q4 2024 was $45.6 million at SELLAS Life Sciences, up from $508000.0 in the prior quarter.
  • The five-year high for Shares Issued was $45.6 million in Q4 2024, with the low at -$26.5 million in Q2 2024.
  • Average Shares Issued over 5 years is $4.8 million, with a median of $388000.0 recorded in 2023.
  • Peak annual rise in Shares Issued hit 74900.0% in 2021, while the deepest fall reached 150.34% in 2021.
  • Over 5 years, Shares Issued stood at $15.1 million in 2020, then plummeted by 119.81% to -$3.0 million in 2021, then soared by 132.1% to $963000.0 in 2022, then crashed by 88.89% to $107000.0 in 2023, then soared by 42521.5% to $45.6 million in 2024.
  • According to Business Quant data, Shares Issued over the past three periods came in at $45.6 million, $508000.0, and -$26.5 million for Q4 2024, Q3 2024, and Q2 2024 respectively.